GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Purchase Of Business

IMGT (XKRX:456570) Purchase Of Business : ₩0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Purchase Of Business?

IMGT's purchase of business for the six months ended in Dec. 2023 was ₩0.00 Mil. It means IMGT spent ₩0.00 Mil on purchasing business. IMGT's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.00 Mil.

Compared with last quarter (₩0.00 Mil in Dec. 2022 ), IMGT spent the same money on purchasing business in Dec. 2023 (₩0.00 Mil).


IMGT Purchase Of Business Historical Data

The historical data trend for IMGT's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Purchase Of Business Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Purchase Of Business
- - - -

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Purchase Of Business - - - -

IMGT Purchase Of Business Calculation

The amount used to purchase business.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Purchase Of Business Related Terms

Thank you for viewing the detailed overview of IMGT's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines